These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 28753097)

  • 21. Monitoring adherence to vulvar lichen sclerosus treatment - a prospective study.
    Zaino ML; Pixley JN; Subramanian VM; Sirdeshmukh D; Feldman SR; Pichardo RO
    J Dermatolog Treat; 2024 Dec; 35(1):2285725. PubMed ID: 38240095
    [No Abstract]   [Full Text] [Related]  

  • 22. Bioavailability, antipsoriatic efficacy and tolerability of a new light cream with mometasone furoate 0.1%.
    Korting HC; Schöllmann C; Willers C; Wigger-Alberti W
    Skin Pharmacol Physiol; 2012; 25(3):133-41. PubMed ID: 22353786
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effectiveness of silk fabric underwear as an adjuvant tool in the management of vulvar lichen simplex chronicus: results of a double-blind randomized controlled trial.
    Corazza M; Borghi A; Minghetti S; Toni G; Virgili A
    Menopause; 2015 Aug; 22(8):850-6. PubMed ID: 25608275
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pimecrolimus 1% cream in the treatment of vulvar lichen sclerosus in postmenopausal women.
    Oskay T; Sezer HK; Genç C; Kutluay L
    Int J Dermatol; 2007 May; 46(5):527-32. PubMed ID: 17472689
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mometasone furoate ointment and cream 0.1 percent in treatment of psoriasis: comparison with ointment and cream formulations of fluocinolone acetonide 0.025 percent and triamcinolone acetonide 0.1 percent.
    Medansky RS; Bressinck R; Cole GW; Deeken JH; Ellis CN; Guin JD; Herndon JH; Lasser AE; Leibsohn E; Menter MA
    Cutis; 1988 Nov; 42(5):480-5. PubMed ID: 3058398
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of Mometasone Furoate Cream Sodium Alginate Skin Repair Mask in Atopic Dermatitis Treatment.
    Ma H; Zhao Y; Xia X
    Altern Ther Health Med; 2024 Nov; 30(11):390-398. PubMed ID: 38430165
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Successful treatment of vulvar lichen sclerosus in a child with low-concentration topical tacrolimus ointment.
    Matsumoto Y; Yamamoto T; Isobe T; Kusunoki T; Tsuboi R
    J Dermatol; 2007 Feb; 34(2):114-6. PubMed ID: 17239148
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A double-blind, randomized prospective study evaluating topical clobetasol propionate 0.05% versus topical tacrolimus 0.1% in patients with vulvar lichen sclerosus.
    Funaro D; Lovett A; Leroux N; Powell J
    J Am Acad Dermatol; 2014 Jul; 71(1):84-91. PubMed ID: 24704090
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Searching for a "Window of Opportunity" in the Treatment of Vulvar Lichen Sclerosus: Evidence for Therapeutic Benefits of an Early Corticosteroid Treatment.
    Borghi A; Flacco ME; Schettini N; Toni G; Corazza M
    Dermatology; 2024; 240(2):195-204. PubMed ID: 38163426
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An arm-based network meta-analysis on treatments for vulvar lichen sclerosus and a call for development of core outcome sets.
    Pergialiotis V; Bellos I; Biliou EC; Varnava P; Mitsopoulou D; Doumouchtsis SK;
    Am J Obstet Gynecol; 2020 Jun; 222(6):542-550.e6. PubMed ID: 31697910
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tacrolimus 0.03% ointment for treatment of paediatric lichen sclerosus: a case series and literature review.
    Mazzilli S; Diluvio L; Di Prete M; Rossi P; Orlandi A; Bianchi L; Campione E
    J Int Med Res; 2018 Sep; 46(9):3724-3728. PubMed ID: 30058419
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vulvar lichen sclerosus: 11 women treated with tacrolimus 0.1% ointment.
    Virgili A; Lauriola MM; Mantovani L; Corazza M
    Acta Derm Venereol; 2007; 87(1):69-72. PubMed ID: 17225019
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Comparison of activity of different topical corticosteroid creams and ointments using a vasoconstriction assay: superiority of hydrocortisone butyrate over hydrocortisone].
    Korting HC; Maslen K; Gross G; Willers C
    J Dtsch Dermatol Ges; 2005 May; 3(5):348-53. PubMed ID: 16372801
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of adapalene in alopecia areata: Efficacy and safety of mometasone furoate 0.1% cream versus combination of mometasone furoate 0.1% cream and adapalene 0.1% gel in alopecia areata.
    Unal M
    Dermatol Ther; 2018 Jan; 31(1):. PubMed ID: 29193637
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Measuring perceived benefit and disease-related burden in patients affected with vulvar lichen sclerosus after a standard topical corticosteroid treatment. Results from a cohort study using Pictorial Representation of Illness and Self-measure and Dermatology Life Quality Index.
    Borghi A; Odorici G; Scuderi V; Valpiani G; Morotti C; Corazza M
    Dermatol Ther; 2020 Nov; 33(6):e14334. PubMed ID: 32974986
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clearance in vulvar lichen sclerosus: a realistic treatment endpoint or a chimera?
    Borghi A; Virgili A; Minghetti S; Toni G; Corazza M
    J Eur Acad Dermatol Venereol; 2018 Jan; 32(1):96-101. PubMed ID: 28796915
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of vulvar lichen sclerosus with topical corticosteroids in children: a study of 72 children.
    Casey GA; Cooper SM; Powell JJ
    Clin Exp Dermatol; 2015 Apr; 40(3):289-92. PubMed ID: 25477189
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bioequivalence of 0.1% mometasone furoate lotion to 0.1% mometasone furoate hydrogel.
    Greive KA; Barnes TM
    Australas J Dermatol; 2016 May; 57(2):e39-45. PubMed ID: 25545549
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vulvar lichen sclerosus: effect of maintenance treatment with a moisturizer on the course of the disease.
    Simonart T; Lahaye M; Simonart JM
    Menopause; 2008; 15(1):74-7. PubMed ID: 17603391
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Does compliance to topical corticosteroid therapy reduce the risk of development of permanent vulvar structural abnormalities in pediatric vulvar lichen sclerosus? A retrospective cohort study.
    Kherlopian A; Fischer G
    Pediatr Dermatol; 2022 Jan; 39(1):22-30. PubMed ID: 34738263
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.